Launch week offerEnds in00h00m00s

annual Promonthly Pro

Hannelore Breitenbach-Koller

PI/Professor

Paris Lodron University of Salzburg

Austria

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Austria Professors in Cell Biology Cell Biology professors in Austria

About

Hannelore Breitenbach-Koller is a Professor at Paris Lodron University Salzburg, Austria. Her research focuses on rare genetic diseases, with recent articles covering topics such as translational readthrough, gene-targeted therapies for epidermolysis bullosa, and the phenotypic alleviation of LAMB3 mutations. Additionally, she explores drug development for ribosomal proteins and the effects of enzyme treatments on fertilization rates.

Articles (7)

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (6)

Norbert Mueller

Professor, Head of the laboratory of NMR

Johannes Kepler Universität Linz Technisch-Naturwissenschaftliche Fakultät

AUSTRIA

View details

Mark Rinnerthaler

AUSTRIA

View details

Campbell W. Gourlay

University of Kent

UNITED KINGDOM

View details

Chris Grant

Professor of Biochemistry

The University of Manchester

UNITED KINGDOM

View details

Thomas Karl

University of Salzburg

AUSTRIA

View details

Gregor Greslehner

Universität Wien

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hannelore Breitenbach-Koller

Research Interests

Make your next move.

Explore related searches

About

Articles (7)

Emerging Personalized Opportunities for Enhancing Translational Readthrough in Rare Genetic Diseases and Beyond.

Recessive Dystrophic Epidermolysis bullosa due to Hemizygous 40 kb Deletion of COL7A1 and the Proximate PFKFB4 Gene Focusing on the Mutation c.425A>G Mimicking Homozygous Status

Phenotypic alleviation in LAMB3-mutated severe junctional epidermolysis bullosa.

Clinical Perspectives of Gene-Targeted Therapies for Epidermolysis Bullosa.

Drug Development for Target Ribosomal Protein rpL35/uL29 for Repair of LAMB3R635X in Rare Skin Disease Epidermolysis Bullosa.

Effect of mild α-chymotrypsin treatment of highly viscous semen samples on fertilization rates.

Slow Growth and Increased Spontaneous Mutation Frequency in Respiratory Deficient <i>afo1</i> <sup>-</sup> Yeast Suppressed by a Dominant Mutation in <i>ATP3</i>.

Collaborators (6)

Norbert Mueller

Mark Rinnerthaler

Campbell W. Gourlay

Chris Grant

Thomas Karl

Gregor Greslehner

Make your next move.